Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vaccines | 4 | 2021 | 3692 | 0.67 | Why? |
| Drugs, Investigational | 1 | 2018 | 198 | 0.59 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.50 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2021 | 10649 | 0.44 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.33 | Why? |
| Bias | 3 | 2021 | 1109 | 0.33 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.30 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.29 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.26 | Why? |
| Epidemics | 2 | 2018 | 6407 | 0.22 | Why? |
| Movement | 1 | 2021 | 232 | 0.19 | Why? |
| Ebola Vaccines | 1 | 2018 | 126 | 0.17 | Why? |
| Population Groups | 1 | 2019 | 212 | 0.16 | Why? |
| Placebos | 1 | 2018 | 629 | 0.15 | Why? |
| Ethics, Research | 1 | 2018 | 328 | 0.14 | Why? |
| Computer Simulation | 2 | 2021 | 4982 | 0.14 | Why? |
| Research Design | 2 | 2021 | 5830 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2021 | 843 | 0.12 | Why? |
| Personnel Staffing and Scheduling | 1 | 2021 | 1578 | 0.11 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.11 | Why? |
| Homes for the Aged | 1 | 2021 | 1071 | 0.11 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.10 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.09 | Why? |
| Poverty | 1 | 2020 | 2302 | 0.09 | Why? |
| Models, Theoretical | 3 | 2021 | 6659 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| New York City | 1 | 2021 | 7432 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Travel | 2 | 2021 | 7220 | 0.07 | Why? |
| Clinical Trials as Topic | 2 | 2020 | 7330 | 0.07 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.07 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Tuberculosis | 1 | 2019 | 2895 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.06 | Why? |
| Humans | 16 | 2021 | 930598 | 0.05 | Why? |
| Voluntary Programs | 1 | 2020 | 22 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Monte Carlo Method | 1 | 2020 | 577 | 0.04 | Why? |
| Forecasting | 2 | 2021 | 4492 | 0.04 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.04 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2021 | 903 | 0.03 | Why? |
| Taiwan | 1 | 2021 | 2556 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Vulnerable Populations | 1 | 2021 | 3099 | 0.02 | Why? |
| Computational Biology | 1 | 2020 | 4514 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.02 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.02 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
| Male | 1 | 2020 | 367725 | 0.00 | Why? |
| Female | 1 | 2020 | 380317 | 0.00 | Why? |